Navigation Links
Sodium Hyaluronate Shows Promise In Treatment Of Shoulder Pain

A novel study conducted by Columbia University Medical Center has shown that sodium hyaluronate, originally intended for use in osteoarthritis, could be effective// in the treatment of chronic shoulder pain as well. Until now, drug treatment with Cox-2 inhibitors or surgery was the only treatment options left for patients with chronic shoulder pain.

Approximately 1.5 million patients visit orthopedic surgeons annually, according to estimates of the National Institute of Musculoskeletal and Skin Diseases. Osteoarthritis and rotator cuff tears account for a majority of the causes for shoulder pain.

The drug was approved by the FDA in the year 1998, for treatment if knee pain in osteoarthritis. A 50% reduction in the shoulder pain following treatment with sodium hyaluronate has been documented. Following such promising results, the drug is being evaluated by the FDA.

The drug, a vital building block of healthy cartilage is being manufactured under the brand name Hyalgan, by Sanofi Aventis, a leading pharmaceutical company. The researchers analyzed the safety and effectiveness of the drug in a group of 602 patients, divided into three groups. One group of the drug received 5 injections of the drug over a period of 6 months. The second group members received 3 drug injections two saline injections, while the third group members received a placebo (five saline injections).

All the study participants had tried other forms of non-surgical therapy, such as physical therapy, steroid injections, oral pain killer medications, all in vain. The patients were subjected to X-ray examination of the shoulder to establish the diagnosis of osteoarthritis and to rule out fractures. The patients during the entire duration of the study were asked to record their pain level on a scale of 1 to 100, with 100 representing the worst pain experienced.

As expected, patients who had received sodium hyaluronate had the greatest reductio n in their pain as revealed by their pain scores of 35 over the six-month period. Those under the second group also had pain reduction, with pain scores of 37, on an average.

The drug treatment was found to be relatively safe, with no adverse effects reported among the three groups. This effect was found to be true when the participants were on drug treatments for other conditions. 14%, 55% and 60% of the study members were on medications for diabetes, arthritis and cardiac problems respectively. The results of this promising study were presented at the annual meeting of the American Academy of Orthopaedic Surgeons, held at Chicago.

More research into treatment of shoulder pain involving sodium hyaluronate, in a considerable number of patients with shoulder pain is needed before this treatment can be approved for clinical use.


'"/>




Related medicine news :

1. Sodium nitrite salt intake found to increases blood flow
2. Americans Consume Far Too Much Salt and Sodium
3. Helicobacter pylori effectively killed by Sodium nitrite
4. Sodium Nitrate Destroys The Bacteria That Plugs The Air Passage In CF Patients
5. Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
6. Altered Sodium Channel Function Linked to Heart Failure
7. Low Blood Sodium When Born Linked to Long Term Sodium Intake
8. Experimental treatment for Ebola Virus Shows promising results in mice
9. New Prostate Cancer Vaccine Shows Promise
10. Ebola Treatment Shows Promise
11. New Drug Shows Significant Improvement In HIV-related Heart Condition
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... N.Y (PRWEB) , ... October 13, 2017 , ... Lori ... became a member of ElderCounsel, a national organization of elder law and special needs ... changing laws and rules. It also provides a forum to network with elder law ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
(Date:10/13/2017)... ... 2017 , ... Ellevate Network, the leading network for professional women, brought together ... equality at their inaugural Summit in New York City in June. The event was ... of over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 West Pharmaceutical ... innovative solutions for injectable drug administration, today announced that ... market opens on Thursday, October 26, 2017, and will ... and business expectations at 9:00 a.m. Eastern Time. To ... 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... Las Piedras, Puerto Rico , where ... Following a comprehensive ... minor structural damage, temporary loss of power and minimal ... completed, manufacturing operations have resumed, and the company expects ...
(Date:10/5/2017)... , Oct. 5, 2017  In response ... of Oral and Maxillofacial Surgeons (AAOMS) released prescribing ... – to be used as a first-line therapy ... Recognizing the ... AAOMS White Paper "Opioid Prescribing: Acute and Postoperative ...
Breaking Medicine Technology: